Grants and Contributions:
Title:
Quantum bio-sensing for next generation health diagnostics
Agreement Number:
981426
Agreement Value:
$272,030.00
Agreement Date:
Oct 28, 2021 - Sep 30, 2025
Description:
Technological advances in imaging instrumentation in the near-infrared (NIR) range (1,000-1,700 nm) have resulted in unparalleled improvements in fluorescence image resolution and depth of penetration in biological tissues, required for highly sensitive and selective biosensors and preclinical in vivo imaging. However, one major limitation for the clinical adoption of NIR imaging is the lack of biocompatible and powerful (high quantum yield, high brightness) NIR emitters. Lanthanide-doped nanoparticles (Ln-NPs) constitute an emerging class of nanomaterials with extraordinary potential to drive innovation in biomolecular imaging and quantum chemical sensing. However, the transformation of these Ln-NPs into multi-modal imaging probes, intelligent bio-sensors and theranostic agents requires innovative design engineering based on understanding of their structure-property relationships, biocompatibility, and nano-bio interactions. The Project will lead to the development of powerful bioprobes capable of non-invasive monitoring of biochemical changes and processes deep in the body and in clinical samples.
Organization:
National Research Council Canada
Expected Results:
In the short term, anticipated outcomes will be strengthened collaborations across industry, academia, and government to support research excellence. In the medium term, anticipated outcomes will be the development of new and potentially disruptive technologies with collaborators. In the long term, find collaborative solutions to public policy challenges and create stronger innovation systems.
Location:
Ottawa, Ontario, CA K1N 6N5
Reference Number:
172-2021-2022-Q3-981426
Agreement Type:
Grant
Report Type:
Grants and Contributions
Recipient Business Number:
119278877
Recipient Type:
Academia
Additional Information:
This agreement has been amended 1 time(s). The end date of this agreement has been modified by 351 days.
Amendment Date
Aug 22, 2024
Recipient's Legal Name:
University of Ottawa
Federal Riding Name:
Ottawa--Vanier--Gloucester
Federal Riding Number:
35081
Program:
Collaborative Science, Technology and Innovation Program - Collaborative R&D Initiatives
Program Purpose:
Collaborate on multiparty research and development programs to catalyze transformative, high-risk, high-reward research with the potential for game-changing scientific discoveries and technological breakthroughs in priority areas.
NAICS Code:
541710 - R&D in the physical, engineering and life sciences
Amendments: